ERYTECH partecipa alle prossime conferenze degli investitori
September 13, 2018 17:30 ET
|
Erytech Pharma S.A.
LIONE, Francia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), una società biofarmaceutica di fase clinica che sviluppa terapie innovative incapsulando...
ERYTECH nimmt an kommenden Investorenkonferenzen teil
September 13, 2018 17:30 ET
|
Erytech Pharma S.A.
LYON, Frankreich, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), ein in der klinischen Entwicklungsphase tätiges Biopharma-Unternehmen, das innovative...
ERYTECH participera à plusieurs conférences d'investisseurs
September 13, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, 13 sept. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext : ERYP – Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant...
ERYTECH to Attend Upcoming Investor Conferences
September 13, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating...
ERYTECH tiendra un webcast le 11 septembre 2018 à l’occasion de ses résultats semestriels 2018
September 06, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, 06 sept. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant...
ERYTECH to Host Second Quarter 2018 Conference Call and Business Update
September 06, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France, Sept. 06, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating...